UNITED STATES pATENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISS IONER FOR PATENTS
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`
`www .uspto.gov
`
`APPLICATION NO.
`
`ISSUE DATE
`
`PATENT NO.
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`14/045,156
`
`10/07/2014
`
`8852636
`
`POZN.P0004US.CP1C2
`
`1032
`
`7590
`09/17/2014
`108197
`
`Parker Highlander PLLC
`
`1 120 South Capital of Texas Highway
`Bldg. 1 , Suite 200
`
`Austin, TX 78746
`
`
`
`The projected patent number and issue date are specified above.
`
`ISSUE NOTIFICATION
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`
`
`
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment is 0 day(s). Any patent to issue from the above-identified application will include
`
`
`
`
`
`an indication of the adjustment on the front page.
`
`If a Continued Prosecution Application (CPA) was filed in the above-identified application, the filing date that
`
`
`
`
`
`
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`
`
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information
`
`
`
`
`
`
`Retrieval (PAIR) WEB site (http://pair.uspto.gov).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the
`
`
`
`
`
`
`
`Office of Patent Legal Administration at (571)-272-7702. Questions relating to issue and publication fee
`
`
`payments should be directed to the Application Assistance Unit (AAU) of the Office of Data Management
`(ODM) at (571 )-272-4200.
`
`
`
`
`
`
`
`
`
`applicants): .uspto.gov for additional APPLICANT(s) (Please see PAIR WEB site http://pair
`
`Pozen Inc., Chapel Hill, NC, Assignee (with 37 CFR 1 .172 Interest);
`
`
`John R. PLACHETKA, Chapel Hill, NC;
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location
`
`
`
`
`
`
`for business investment, innovation, and commercialization of new technologies. The USA offers tremendous
`
`
`
`resources and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation
`
`
`
`
`
`
`works to encourage and facilitate business investment. To learn more about why the USA is the best country in
`
`
`
`
`the world to develop technology, manufacture products, and grow your business, visit SelectUSA.gov.
`
`IR103 (Rev. 10/09)
`
`

`
`Receipt date: 07/31/2014
`
`Form PT0-1449 (modified)
`
`14045156 - GAU: 1 618
`
`Page 8 of 29
`
`Atty. Docket No.:
`
`POZN.P0004US.CP1 C2
`14/045,156
`
`I Serial No.:
`I Group:
`SeePage 1-7 I
`See Page 7-11 I
`
`
`
`
`List of Patents and Publications for Applicant's Applicant:
`John R. PLACHETKA
`
`
`INFORMATION DISCLOSURE STATEMENT
`
`(Use several sheets if necessary)
`Foreign Patent Documents
`U.S. Patent Documents
`
`Filing Date:
`October 3, 2013
`
`1618
`
`Other Art
`See Page 11-29
`
`Foreign Patent Documents
`
`Exam. Ref. Document Date
`I nit. Des. Number
`
`Country
`
`Name
`
`B 1 0
`
`EP 0 244 3 80
`
`1 1/04/87
`
`Europe
`
`Haessle AB
`
`B11
`
`EP 0 320 550 06/21/89
`
`Europe
`
`Bristol Myers Co.
`
`B 1 2
`
`EP 0 3 2 0 5 5 1 06/21/89
`
`Europe
`
`Bristol Myers Co.
`
`B 1 3 E P 0 426 479 A 1 05/08/91
`
`Europe
`
`McNeil PPC Inc.
`
`B 1 4 E P 0 426 479 B l 05/08/91
`
`Europe
`
`McNeil PPC Inc.
`
`B 1 5
`
`EP 0 5 5 0 083 07/07/93
`
`Europe
`
`Glaxo Group Ltd.
`
`B 1 6
`
`EP 1 020 461 07/19/00
`
`Europe
`
`AstraZeneca AB
`
`B 1 7
`
`EP 1 068 867 0 1/17/01
`
`Europe
`
`Bernard Charles Sherman
`
`B 1 8
`
`EP 1 4 1 1 900 07/21/10
`
`Europe
`
`Pozen Inc.
`
`B 1 9
`
`EP 1 726 300 1 1/29/06
`
`Europe
`
`Flamel Technologies
`
`B20
`
`EP 1 726 3 0 1 1 1/29/06
`
`Europe
`
`Flamel Technologies
`
`B2 1
`
`GB 2 1 05 193 03/23/83 United Kingdom
`
`Glaxo Group Limited
`
`B22
`
`GB 2 1 63 747 03/05/86 United Kingdom
`
`Nippon Chemiphar Co.
`
`B23
`
`GB 2 2 1 6 4 1 3 1 0/11/89 United Kingdom
`
`Glaxo Limited Group
`
`B24
`
`JP 2005- 145894 06/09/05
`
`Japan
`
`Takeda Chemical Industries Ltd.
`Japanese (English abstract)
`
`B25 wo 1985/003433 08/15/85
`B26 wo 1990/006925 06/28/90
`wo 1991/0 16886 1 1/14/91
`B27
`wo 1991/0 16895 1 1/14/91
`wo 1991/0 16896 1 1/14/91
`B29
`wo 1991/0 1 97 1 1 12/26/91
`pplied B30
`'
`wo 1991/019712 12/26/91
`B31
`B32 wo 1993/0 1 1 750 � ��·� ��·9 i
`
`B28
`
`{00160713}
`
`06/24/9)
`
`WIPO
`
`WIPO
`
`WIPO
`
`WIPO
`
`WIPO
`
`WIPO
`
`WIPO
`
`WIPO
`
`Gustavsson et al.
`
`
`
`Aktiebolaget Hassle
`
`G.D. Searle & Co.
`
`G.D. Searle & Co.
`
`G. D. Searle & Co.
`
`
`
`Aktiebolaget Astra
`
`
`
`Aktiebolaget Astra
`
`Fuisz Technologies Ltd.
`
`EXAMINER: /Nissa Westerberg/
`DATE CONSIDERED: 08/14/20! 4
`
`
`
`
`
`EXAMINER: INITIAL IF REFERENCE CONSIDERED, WHETHER OR NOT CITATION IS IN CONFORMANCE WITH MPEP609; DRAW LINE THROUGH
`
`
`
`
`CITATION IF NOT IN CONFORMANCE AND NOT CONSIDERED. INCLUDE COPY OF THIS FORM WITH NEXT COMMUNICATION TO APPLICANT.
`
`
`
`INFORMATION DISCLOSURE STATEMENT- PT0-1449 (MODIFIED)
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED TH ROUGH. /N.M.W.i
`
`

`
`Receipt date: 07/31/2014
`
`Form PT0-1449 (modified)
`
`14045156 - GAU: 1 618
`
`Page 5 of 29
`
`Atty. Docket No.:
`
`POZN.P0004US.CP1 C2
`14/045,156
`
`
`
`
`List of Patents and Publications for Applicant's Applicant:
`John R. PLACHETKA
`
`
`INFORMATION DISCLOSURE STATEMENT
`
`(Use several sheets if necessary)
`U.S. Patent Documents
`Foreign Patent Documents
`See Page 7-11
`
`Filing Date:
`October 3, 2013
`
`1618
`
`Other Art
`See Page 11-29
`
`I Serial No.:
`I Group:
`I
`
`SeePage 1-7 I
`
`Exam. Ref.
`I nit. Des.
`
`Document
`Number
`
`A l 0 1
`
`5,750,531
`
`Date
`
`Name
`
`05/12/98
`
`1 0/06/98
`
`1 0/06/98
`
`1 1/24/98
`
`02/16/99
`
`03/02/99
`
`Lee et al.
`
`Bergstrand et al.
`
`Roche et al.
`
`Phillips
`
`Plachetka
`
`Lindberg et al.
`
`5,81 7,338
`
`5,817,340
`
`5,840,737
`
`5,872,145
`
`5,877,192
`
`5,900,424
`
`05/04/99
`
`Kallstrom et al.
`
`5,955,451
`
`6,01 3,28 1
`
`09/21/99
`
`0 1/11/00
`
`
`
`Lichtenberger et al.
`
`Lundberg et al.
`
`6,025,395
`
`02/15/00
`
`Breitner et al.
`
`A102
`
`A103
`
`A104
`
`A105
`
`A106
`
`A107
`
`A108
`
`A109
`
`A11 0
`
`A11 1
`
`6,060,499
`
`05/09/00
`
`Plachetka
`
`A112
`.l· J A11 3
`'II ��
`Change(s) a
`
`to documen A114
`l-
`A11 5
`/C.C.D/
`8/29/2014-
`
`A11 6
`
`6,093,734
`r
`
`r,r o ,,
`
`6,132,768
`
`6,132,771
`
`07/25/00
`
`12/19/00
`
`1 0/17/00
`
`1 0/17/00
`
`6,1 3 6,344
`
`1 0/24/00
`
`A11 7
`
`A11 8
`
`A119
`
`A120
`
`A121
`
`A122
`
`A123
`
`A124
`
`A125
`
`6,160,020
`
`6,1 62,816
`
`6,183,776
`
`6,183,779
`
`6,207,1 88
`
`6,231 ,888
`
`12/12/00
`
`12/19/00
`
`02/06/01
`
`02/06/01
`
`03/27/01
`
`05/15/0 1
`
`6,287,600
`
`09/11/0 1
`
`6,365,1 84
`
`6,369,085
`
`04/02/02
`
`04/09/02
`
`{00160713}
`
`Garst et al.
`Bohlin et al. 6, 162,
`816
`
`Sachs et al.
`
`Depui et al.
`
`Depui et al.
`
`Ohannesian et al.
`
`Bohlin et al.
`
`Depui et al.
`
`Ouali et al.
`
`Gustavsson et al.
`
`Lerner et al.
`
`Ouali e t al.
`
`Depui et al.
`
`Cotton et al.
`
`EXAMINER: /Nissa Westerberg/ DATE CONSIDERED: 08/05i201 4
`
`
`
`
`
`
`EXAMINER: INITIAL IF REFERENCE CONSIDERED, WHETHER OR NOT CITATION IS IN CONFORMANCE WITH MPEP609; DRAW LINE THROUGH
`
`
`
`
`CITATION IF NOT IN CONFORMANCE AND NOT CONSIDERED. INCLUDE COPY OF THIS FORM WITH NEXT COMMUNICATION TO APPLICANT.
`
`
`
`INFORMATION DISCLOSURE STATEMENT- PT0-1449 (MODIFIED)
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /N.M.W.i
`
`

`
`I Serial No.:
`I Group:
`I
`
`Filing Date:
`October 3, 2013
`
`1618
`
`Other Art
`See Page 11-29
`
`Receipt date: 07/31/2014
`
`Form PT0-1449 (modified)
`
`14045156 - GAU: 1 618
`
`Page 4 of 29
`
`Atty. Docket No.:
`
`POZN.P0004US.CP1 C2
`14/045,156
`
`
`
`
`List of Patents and Publications for Applicant's Applicant:
`John R. PLACHETKA
`
`
`INFORMATION DISCLOSURE STATEMENT
`
`(Use several sheets if necessary)
`U.S. Patent Documents
`Foreign Patent Documents
`See Page 7-11
`
`SeePage 1-7 I
`
`Exam. Ref.
`I nit. Des.
`
`Document
`Number
`
`Date
`
`Name
`
`A76
`
`A77
`
`A78
`
`A79
`
`A80
`
`A81
`
`A82
`
`A83
`
`A84
`
`A85
`
`A86
`
`4,965,065
`
`1 0/23/90
`
`Lukacsko et al.
`
`5,026,560
`
`06/25/91
`
`07/30/91
`
`08/06/91
`
`08/27/91
`
`09/24/91
`
`Makino et al.
`
`Saeki et al.
`
`Lukacsko et al.
`
`Lukacsko et al.
`
`Panoz et al.
`
`03/03/92
`
`Makino et al.
`
`04/20/93
`
`Goldman et al.
`
`1 1/09/93
`l't,�l'�I�'H
`12/13/94
`
`Lukacsko et al.
`Singer et al. 11/1
`994-
`
`Fawzi et al.
`
`5,035,899
`
`5,037, 8 1 5
`
`5,043,358
`
`5,051,262
`
`5,093,132
`
`5,204,1 1 8
`
`5,260,333
`
`5,364,61 6
`
`5,373,022
`
`��l· ... �
`Change(s) a
`
`r r
`to document
`/C.C.D/
`8/29/2014-
`
`A87
`
`A88
`
`A89
`
`A90
`
`A91
`
`A92
`
`A93
`
`A94
`
`A95
`
`A96
`
`A97
`
`A98
`
`A99
`
`5,409,709
`
`04/25/95
`
`Ozawa et al.
`
`5,417,980
`
`05/23/95
`
`Goldman et al.
`
`5,466,436
`
`1 1/14/95
`
`5,514,663
`
`05/07/96
`
`5,60 1 , 843
`
`5,631,022
`
`5,643,960
`
`5,667,802
`
`02/11/97
`9�1�9!1.94
`07/01/97
`
`09/16/97
`
`5,679,376
`
`1 0/21/97
`
`5,686,1 05
`
`1 1/11/97
`
`Stables
`
`Mandel
`
`Gimet
`
`05/
`1997
`Mandel et al.
`
`Breitner et al.
`
`Grim berg
`
`Stevens et al.
`
`Kelm et al.
`
`5,690,960
`
`1 1/25/97
`
`Bengtsson et al.
`
`5,702,723
`
`12/30/97
`
`Griffin
`
`5,714,504
`
`02/03/98
`
`Lindberg et al.
`
`A100
`
`5,716,648
`
`02/10/98
`
`Halskov et al.
`
`{00160713}
`
`EXAMINER: /Nissa Westerberg/ DATE CONSIDERED: 08/05i201 4
`
`
`
`
`
`
`EXAMINER: INITIAL IF REFERENCE CONSIDERED, WHETHER OR NOT CITATION IS IN CONFORMANCE WITH MPEP609; DRAW LINE THROUGH
`
`
`
`
`CITATION IF NOT IN CONFORMANCE AND NOT CONSIDERED. INCLUDE COPY OF THIS FORM WITH NEXT COMMUNICATION TO APPLICANT.
`
`
`
`INFORMATION DISCLOSURE STATEMENT- PT0-1449 (MODIFIED)
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /N.M.W.i
`
`

`
`Receipt date: 07/31/2014
`
`Form PT0-1449 (modified)
`
`14045156 - GAU: 1 618
`
`Page 3 of 29
`
`Atty. Docket No.:
`
`POZN.P0004US.CP1 C2
`14/045,156
`
`
`
`
`List of Patents and Publications for Applicant's Applicant:
`John R. PLACHETKA
`
`I Serial No.:
`I Group:
`I
`
`
`INFORMATION DISCLOSURE STATEMENT
`
`(Use several sheets if necessary)
`U.S. Patent Documents
`Foreign Patent Documents
`See Page 7-11
`
`SeePage 1-7 I
`
`Filing Date:
`October 3, 2013
`
`1618
`
`Other Art
`See Page 11-29
`
`Exam. Ref.
`I nit. Des.
`
`Document
`Number
`
`Date
`
`Name
`
`A5 1
`
`A52
`
`A53
`
`A54
`
`A55
`
`A 56
`
`A 57
`
`A58
`
`A59
`
`A60
`
`2009-0297594
`
`12/03/09
`
`2010-0062064
`
`03/11/10
`
`Depui et al.
`
`Ault et al.
`
`2010-01 72983
`
`07/08/10
`
`Plachetka
`
`2010-0178334
`
`07/15/10
`
`
`
`Johansson et al.
`
`2010-033 0 1 79
`
`12/30/10
`
`Ault et al.
`
`2012-0064156
`
`03/15/12
`
`2013-0078305
`
`03/28/13
`
`Plachetka
`
`Plachetka
`
`4,198,390
`
`04/15/80
`
`Rider
`
`4,255,431
`
`4,344,929
`
`03/10/8 1
`
`08/17/82
`
`Junggren et al.
`
`Bonsen et al.
`
`A6 1
`nnli,..,-4
`A62
`Change(s) a
`
`I I
`A63
`to document
`/C.C.E>/
`8/29/2014-
`
`A65
`
`A64
`
`A66
`
`A67
`
`A68
`
`A69
`
`A70
`
`A7 1
`
`A72
`
`A73
`
`A74
`
`A75
`
`{00160713}
`
`4,508,905
`
`4,554,276
`
`4,562,261
`
`4,619,934
`
`04/02/85
`��'It �'IB'2
`12/31/85
`
`Junggren et al.
`LaMa tina 1 l/1985
`Hirata et al.
`
`1 0/28/86
`
`Sunshine et al.
`
`4,676,984
`
`06/30/87
`
`4,704,278
`
`1 1/03/87
`
`Wu etal.
`
`Wu etal.
`
`4,726,951
`
`02/23/88
`
`Panoz et al.
`
`4,738,974
`
`04/19/88
`
`Brandstrom
`
`4,757,060
`
`07/12/88
`
`
`
`Lukacsko et al.
`
`4,758,579
`
`07/19/88
`
`Kohl et al.
`
`4,766,1 17
`
`08/23/88
`
`Crawford et al.
`
`4,786,505
`
`1 1/22/88
`
`4,853,230
`
`08/01/89
`
`4,865,847
`
`4,948,58 1
`
`09/12/89
`
`08/14/90
`
`Lovgren et al.
`
`Lovgren et al.
`
`Gosswein
`
`Sawayangi et al.
`
`EXAMINER: /Nissa Westerberg/ DATE CONSIDERED: 08/05i201 4
`
`
`
`
`
`
`EXAMINER: INITIAL IF REFERENCE CONSIDERED, WHETHER OR NOT CITATION IS IN CONFORMANCE WITH MPEP609; DRAW LINE THROUGH
`
`
`
`
`CITATION IF NOT IN CONFORMANCE AND NOT CONSIDERED. INCLUDE COPY OF THIS FORM WITH NEXT COMMUNICATION TO APPLICANT.
`
`
`
`INFORMATION DISCLOSURE STATEMENT- PT0-1449 (MODIFIED)
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /N.M.W.i
`
`

`
`Receipt date: 07/31/2014
`
`Form PT0-1449 (modified)
`
`14045156 - GAU: 1 618
`
`Page 1 of 29
`
`Atty. Docket No.:
`
`POZN.P0004US.CP1 C2
`14/045,156
`
`
`
`
`List of Patents and Publications for Applicant's Applicant:
`John R. PLACHETKA
`
`I Serial No.:
`I Group:
`I
`
`
`INFORMATION DISCLOSURE STATEMENT
`
`(Use several sheets if necessary)
`U.S. Patent Documents
`Foreign Patent Documents
`See Page 7-11
`
`SeePage 1-7 I
`
`Filing Date:
`October 3, 2013
`
`1618
`
`Other Art
`See Page 11-29
`
`Exam. Ref.
`I nit. Des.
`
`Document
`Number
`
`Date
`
`Name
`
`A1
`
`A2
`
`A3
`
`A4
`
`A5
`
`A6
`
`A7
`
`A8
`
`2001-00251 07
`
`09/27/0 1
`
`Barberich et al.
`
`2002-0012676
`
`01/31/02
`
`Lundberg et al.
`
`2002-0042433
`
`04/11/02
`
`Yelle et al.
`
`2002-0044962
`
`04/18/02
`
`Cherukuri et al.
`
`2002-00451 84
`
`04/18/02
`
`2002-0051 8 1 4
`
`05/02/02
`
`Chen
`
`Chen
`
`2002-0086029
`
`07/04/02
`
`Lundberg et al.
`
`2002-0090395
`
`07/11/02
`
`W oolfe et al.
`
`2002-0 1 11370
`
`2002-01 5 5 1 53
`
`2002-0160046
`
`08/15/02
`t����''62
`1 0/31/02
`
`Bergman et al.
`
`02
`Depui et al. 10/20
`
`Robinson et al.
`
`A12
`
`2003-0008903
`
`01/09/03
`
`A9
`nnli,ri
`A10
`Change(s) a
`
`I I
`A l l
`to document
`/C.C.5/
`8/29/201+
`
`Al3
`
`A14
`
`A15
`
`A16
`
`A17
`
`A 1 8
`
`A19
`
`A20
`
`A21
`
`A22
`
`A23
`
`A24
`
`A25
`
`2003-0040537
`
`2003-0069255
`
`2003-01 13375
`
`2003-0129235
`
`2003-021 5527
`
`02/27/03
`s s,•s"''e�
`06/19/03
`
`07/10/03
`
`1 1/20/03
`
`Barberich et al.
`
`
`
`Plachetka et al.
`
`Plachetka
`
`
`
`04-/ 200)
`
`Lundberg et al.
`
`Chen et al.
`
`Phillips
`
`2003-0232080
`
`12/18/03
`
`Pather et al.
`
`2003-0232876
`
`12/18/03
`
`Plachetka
`
`2004-0022846
`
`02/05/04
`
`Depui et al.
`
`2004-0048896
`
`03/11/04
`
`Phillips
`
`2004-01 2 1 004
`
`2004-01 31676
`
`2004-01 7 1 646
`
`06/24/04
`
`07/08/04
`
`09/02/04
`
`Taneja
`
`Taneja
`
`Phillips
`
`2004-0180089
`
`09/16/04
`
`
`
`Plachetka et al.
`
`{00160713}
`
`EXAMINER: /Nissa Westerberg/ DATE CONSIDERED: 08/05/2014
`
`
`
`
`
`EXAMINER: INITIAL IF REFERENCE CONSIDERED, WHETHER OR NOT CITATION IS IN CONFORMANCE WITH MPEP609; DRAW LINE THROUGH
`
`
`
`
`CITATION IF NOT IN CONFORMANCE AND NOT CONSIDERED. INCLUDE COPY OF THIS FORM WITH NEXT COMMUNICATION TO APPLICANT.
`
`
`
`INFORMATION DISCLOSURE STATEMENT- PT0-1449 (MODIFIED)
`ALL REFERENCES CONSi DERED EXCEPT WHE RE LINED THROUGH. /N. M.W./
`
`

`
`PATENT
`
`
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`In re Application
`of: John R. PLACHETKA Group Art Unit: 1 6 1 8
`
`Serial No. : 14/045 , 1 56
`
`
`
`Examiner: Nissa M. Westerberg
`
`Filing Date: October 3, 201 3
`
`
`
`Attorney Docket No. : POZN.P0004US.CP1C2
`
`Title: PHARMACEUTICAL
`
`COMPOSITIONS FOR THE
`COORDINATED DELIVERY OF
`NSAIDS
`
`Confirmation No. : 1 032
`
`
`
`CERTIFICATE OF ELECTRONIC TRANSMISSION
`
`I hereby certify that this correspondence is being electronically filed with the
`
`
`
`
`United States Patent and Trademark Office via EFS-Web on the date below:
`
`September 8. 201 4
`
`Date
`
`/Steven L. Highlander/
`Steven L. Highlander
`
`RESPONSE TO EXAMINER'S INTERVIEW SUMMARY
`
`Commissioner for Patents
`P.O. Box 1450
`
`
`
`Alexandria, Virginia 22313-1450
`
`Sir:
`
`
`
`
`
`
`
`
`
`This paper is submitted to summarize the substance of the August 1 , 2014 telephonic
`
`
`
`
`
`interview between Examiner Westerberg and Applicant's representative, Steven L. Highlander.
`
`
`
`
`
`
`
`
`
`It is believed that no fee is due; however, should any fees under 37 C.P.R. §§ 1 . 16 to 1 .2 1
`
`
`
`
`
`b e required for any reason, the Commissioner i s authorized to deduct said fees from Parker
`
`
`
`
`
`Highlander PLLC Account No. : 50-5902/POZN.P0004US.CP1C2.
`
`{00174088}
`
`1
`
`

`
`INTERVIEW REMARKS
`
`
`
`
`
`
`
`
`
`Applicants concur with and adopt the examiner's characterization of the August 1 , 2014
`
`interview, as set forth in the Interview Summary mailed on August 8, 2014.
`
`
`
`The examiner is invited to contact the undersigned attorney with any questions, comments or
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`suggestions relating to the referenced patent application.
`
`
`
`
`
`Respectfully submitted,
`
`/Steven L. Highlander/
`
`Steven L. Highlander
`Reg. No. 37,642
`Attorney for Applicant
`
`Parker Highlander PLLC
`
`
`l l20 S . Capital of Texas Highway
`
`Building One, Suite 200
`
`Austin, Texas 78746
`
`5 12-334-2900 (Telephone)
`
`5 12-334-2999 (Fax)
`
`Date: September 8, 2014
`
`{00174088}
`
`2
`
`

`
`
`
`Electronic Acknowledgement Receipt
`
`
`
`EFSID:
`
`20073739
`
`
`
`Application Number:
`
`14045156
`
`
`
`
`
`International Application Number:
`
`
`
`Confirmation Number:
`
`1032
`
`Title of Invention:
`
`
`
`PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF
`
`
`
`
`NSAIDS
`
`
`
`First Named Inventor/Applicant Name:
`
`
`
`John R. PLACHETKA
`
`Customer Number:
`
`108197
`
`Filer:
`
`
`
`Steven Lee Highlander/Christopher Jackson
`
`Filer Authorized By:
`
`Steven Lee Highlander
`
`Attorney Docket Number:
`
`
`
`POZN.P0004US.CP1 C2
`
`Receipt Date:
`
`08-SEP-2014
`
`
`
`Filing Date:
`
`03-0CT-2013
`
`TimeStamp:
`
`15:07:15
`
`
`
`Application Type:
`
`
`
`Utility under 35 USC 111 (a)
`
`Payment information:
`I no
`
`Submitted with Payment
`
`File Listing:
`
`Document
`Number
`
`1
`
`Document Description
`
`File Name
`
`2
`
`File Size( Bytes)/ Multi Pages
`
`Message Digest Part /.zip (ifappl.)
`38525
`
`
`Applicant summary of interview with POZNP0004USCP1 C2_1NTSUM
`
`no
`examiner
`M.pdf
`
`
`e39eebde23f8451 d9e4aaf323696ba21 eb9
`b1c8b
`
`Warnings:
`
`Information:
`
`

`
`Total Files Size (in bytes)
`
`38525
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`
`
`
`
`
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`
`Post Card, as described in MPEP 503.
`
`New Applications Under 35 U.S.C. 1 1 1
`
`If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`
`
`
`
`
`
`
`1 .53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1 .54) will be issued in due course and the date shown on this
`
`
`
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International Application under 35 U.S.C. 371
`
`
`
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`
`
`
`
`
`
`
`
`U.S.C. 371 and other applicable requirements a Form PCT/DO/E0/903 indicating acceptance of the application as a
`
`
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New International Application Filed with the USPTO as a Receiving Office
`
`
`
`If a new international application is being filed and the international application includes the necessary components for
`
`
`
`
`
`
`
`
`
`an international filing date (see PCT Article 1 1 and MPEP 1 81 0), a Notification of the International Application Number
`Date (Form PCT/R0/1 OS) will be issued in due course, subject to prescriptions
`
`and of the International Filing
`concerning
`
`
`
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`

`
`
`
`ClJRRENT CORRESPONDENCE ADDRESS (Note: Use Block 1 fGr cmy
`
`chJ11ge of Jcic'•Te::s)
`
`08108/20 l4
`759G
`108197
`
`Parker Highlander PLLC
`
`1120 South Capital of Texas High\vay
`Bldg" l, Suite 200
`
`Austin, TX 78746
`
`PA.RT B -FEE(S) TRANSMITTAL
`
`
`Complete and send this form, together with applicable fee(s), to: Mail Mail Stop ISSUE FEE
`
`
`Commissioner for Patents
`P.Oo Box 1450
`Virginia 22313-1450
`Alexandria,
`(571)-273-2885
`or Fax
`Blocks l through 5 should be completed where
`.. All furt..�er
`INSTRllCTIONS: This forrn should be used for transmitting the ISSUE FEE and PUBLICATION FEE (if required)"
`
`
`
`
`the Patent, advance orders and notification of maintenance fees \viH be n1,1:ded to the current correspondence
`
`correspondence including
`address as
`appropn,1te
`
`
`
`
`
`
`indicated unless corrected below or directed otherwise in Block 1, by (a) specifying a new CfJrrespondence address; and/or (b) indicating a separate '1:;EE A.DDRESS:! for
`
`rnaintenance fee notifications.
`Nc•te: A. certificate
`of mailing can only be used for domestic rnailings of the
`
`Each o.a .. kl.it�onal paper.s.
`cannot he used for any other accon1panying
`
`f<ee(s) Transrnitt,lL Th:ts certJficate
`
`p51per:-..such as an a�si�nment or forrnal drawing, nnlst
`
`have 1ts own cert1f1cate of maJung or transnl!SSJon.
`
`Certi!1cate
`I hereby certify that this Fee(s,l Transrnittal
`of Mailing or Transmission
`
`is being deposited \vjth the United
`
`
`Stale'; Postal Service with sufficient pmtage for first class mail in an envelope
`addressed to the Jv1ail Stop lSS1JE FEE address above, or being facsirrdJe
`
`
`transmitted to L.'le USPTO (571) 273-2885, on the date indicated below.
`
`Steven L. Hig�;iander
`/Steven L Highlander/
`August26, 2014
`
`(Signature!
`(Date!
`
`APPLICATION NO"
`
`F!Lll'iG DATE
`
`Flc'<.ST NAMED INVENTOR
`
`ATTORNEY DOCKET NO"
`
`CONFIRMATION NO"
`
`John R. PLACHETKA
`l4/045,J 56
`
`POZN .P0004US.CP JC2
`TITLE OF INVENTION: PHARJVV\ CEUTIC'\L COMPOSITIONS FORTI-IE COORDINATED DELIVERY OF NSAIDS
`
`l0/03/2013
`
`l032
`
`APPLN.TYPE
`
`ENTITY STATTJS
`
`ISSTJE FEE DUE
`
`nonprovi ;ional UNDISCOUNTED
`
`$960
`
`PUBLICATION FEE DUE PREV" PAID ISSUE FEE TOTAL FEE(Sl D<JE
`so
`
`$960
`
`$0
`
`DATE DUE
`
`11/10/2014
`
`EXAMil'-lER
`
`ARTTJNJT
`
`CI"ASS-STJBCLASS
`
`1618
`
`424-,163000
`
`WESTERBERG, NISSA ?vi
`'
`"
`
`
`Change of correspondence address or indication of !oFee Address'! (37
`2. For printing on the patent front page, Hst
`
`0) The n,1mes of up to 3 regJstered
`CFR 1.363)"
`patent ,1ttorneys
`0 Change of _c?rrespondence
`
`
`address (or Change of Correspondence or agents OR, alternatively,
`(2) The narne of a sjn2le finn (havjruz
`Address torm PTO/SB!l22) att.1ched.
`as a rnernber a
`0 "Fee Addres';''
`
`
`regio:tered attorney or�agent) and the� names of up to
`
`
`
`indication (or "Fee Address'' Indication form
`PTOiSB/47; Rev 03-02 or more recent) attached. Ust' of a Customc:r
`Number is required,
`
`
`2 registered patent attorneys or agents. Jf no narne is
`
`listed, no name will be printed"
`
`1 Parker Highlander PLLC
`
`3_
`
`below, no assjgnee data \VHl appear on the patent. Jf an assignee js identified below, the docurnent has been fHed for
`
`
`
`
`
`3. ASSIGJ'<'EE NA.L\IIE i\.c"-iD RESIDENCE DATA TO BE PRINTED ON THE PATENT (print or type)
`PLEASE _NlYJE: UnJess an assignee is jdentifjed
`_ Completion of this form is NOT a substitute
`
`
`in 37 CFR J. J J
`
`recordation as ';et forth
`
`for filing an assignment.
`(A) NANIE OF ASSIGNE E
`(B) RESlDENCE; (CITY and STATE OR COUNTRY)
`Pozen Inc.
`Chapel Hill, NC
`(will not be printed on the patent): 0 Individual 0 Corpor,ltion or other private group entity 0 Government
`
`4b. Payment ofFee(s): (Plea;,., fh·;;t reapply any pn�viously
`0 A check i'; enclosed.
`f[} Payment by credit cm·d" f"um PT0-2538 is .ctt.cchtd. Via EFS-Vv'eb.
`t(! charge t)1e r�S-lllj�"Xd fee(s), '�ny defjcjency,
`or crf�fHt_s any
`�The Djrector is hereby �wthorized
`
`Account Number ___ ;;,_Q::.)_\:!Q_�-------
`overpayment to Depos:t
`(enc!me an extra copy oi tluo: formr
`
`Please check the .1ppropnate ,1ssignee c,1tegory or categories
`
`paid issut' ft'e shown ahow}
`
`4a. The following fee( s) are subm!tled:
`
`iKi Issue
`Fee
`0 Publication
`Fee (No small emily discount pennitted)
`0 Ad1hlnce Order--#of Copies _
`5. Change in Entity Status (from status indicated
`above)
`0 Applicant certifying
`NOTE: Absent a valid certification of Micro Entity Slalus (see formo: PTO/SB!15A and l5B), issue
`
`micro entity status" See 37 CFR 1.29
`
`fee payrnent in the rrJicro entity arnown \viU not be accepted at the risk of appHcatjon abandonrr.�ent.
`0 AppHcant assert:tng
`!:SDJ:I;;_� If the application
`See 37 CI:<R J .27
`
`was previously under micro entity status, checking this box wilJ be taken
`smnU entity status.
`
`
`to be a notification of loss of entitlement to rnicro entity status.
`l.J Applicant changing to regular undiscounted fee status.
`
`
`_NOTE: Checking this box wiH be taken to be a notjfication of loss of entitJernent to srnaH or rnicro
`
`entity status, as applicable"
`
`NOTE: This form must be signed in accordance with 37 CFR Lll and l 33. See 37 CFR 1.4 for sign,lture
`
`
`reg_uiremems and certific,1tions.
`
`Typed or printed name _____ :::ltE)_\fE!_rl ___ �· __ i::l_ig_Qiander
`
`PTOL-85 Part B (l0-13)
`Approved for me through l0/31/2013"
`
`Page 2 of 3
`OMB 0651-0033 US Patent and Trademark Office; U"S. DEPARTMENT OF COMMERCE
`
`

`
`
`
`Electronic Patent Application Fee Transmittal
`
`
`
`
`
`Application Number:
`
`14045156
`
`
`
`Filing Date:
`
`03-0ct-2013
`
`Title of Invention:
`
`
`
`PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF
`
`
`
`
`NSAIDS
`
`First Named Inventor/Applicant Name:
`
`John R. PLACHETKA
`
`Filer:
`
`
`
`Steven Lee Highlander/Richard Ortiz
`
`Attorney Docket Number:
`
`
`
`POZN.P0004US.CP1 C2
`
`Filed as Large Entity
`
`Utility under 35 USC 111 (a) Filing Fees
`
`Description
`
`Fee Code Quantity
`
`Amount
`
`Sub-Total in
`USD($)
`
`Basic Filing:
`
`Pages:
`
`Claims:
`
`
`
`Miscellaneous-Filing:
`
`Petition:
`
`
`
`Patent-Appeals-and-Interference:
`
`Post-Allowance-and-Post-Issuance:
`
`
`
`Utility Appllssue Fee
`
`1501
`
`1
`
`960
`
`960
`
`Extension-of-Time:
`
`

`
`Description
`
`Fee Code Quantity
`
`Amount
`
`Sub-Total in
`USD($)
`
`Miscellaneous:
`
`Total in USD ($)
`
`960
`
`

`
`
`
`Electronic Acknowledgement Receipt
`
`
`
`EFSID:
`
`19966643
`
`
`
`Application Number:
`
`14045156
`
`
`
`
`
`International Application Number:
`
`
`
`Confirmation Number:
`
`1032
`
`Title of Invention:
`
`
`
`PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF
`
`
`
`
`NSAIDS
`
`
`
`First Named Inventor/Applicant Name:
`
`
`
`John R. PLACHETKA
`
`Customer Number:
`
`108197
`
`Filer:
`
`
`
`Steven Lee Highlander/Richard Ortiz
`
`Filer Authorized By:
`
`Steven Lee Highlander
`
`Attorney Docket Number:
`
`
`
`POZN.P0004US.CP1 C2
`
`Receipt Date:
`
`26-AUG-2014
`
`
`
`Filing Date:
`
`03-0CT-2013
`
`TimeStamp:
`
`13:52:51
`
`
`
`Application Type:
`
`
`
`Utility under 35 USC 111 (a)
`
`Payment information:
`I no
`
`Submitted with Payment
`
`File Listing:
`
`Document
`Number
`
`1
`
`Document Description
`
`File Name
`
`File Size( Bytes)/ Multi Pages
`
`Message Digest Part /.zip (ifappl.)
`1603067
`POZNP0004USCP1 C2-lssue-
`
`no
`Issue Fee Payment (PT0-85B)
`Fee-Trans-Letter.pdf
`
`3742530248b5644b805cf9a5a36131 a6dd0
`9cc22
`
`1
`
`Warnings:
`
`Information:
`
`

`
`2
`
`
`
`Fee Worksheet (SB06)
`
`fee-info. pdf
`
`30330
`no
`
`
`Of2 7 dfd ea 7 ed42312 946a4bfd80eba5 bb 7 c
`58a8b
`
`2
`
`Warnings:
`
`Information:
`
`Total Files Size (in bytes)
`
`1633397
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`
`
`
`
`
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`
`Post Card, as described in MPEP 503.
`
`New A��lications Under 35 U.S.C. 1 1 1
`
`If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`
`
`
`
`
`
`
`1 .53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1 .54) will be issued in due course and the date shown on this
`
`
`
`Acknowledgement Receipt will establish the filing date of the application.
`
`National Stage of an International A��lication under 35 U.S.C. 371
`
`
`
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`
`
`
`
`
`
`
`
`U.S.C. 371 and other applicable requirements a Form PCT/DO/E0/903 indicating acceptance of the application as a
`
`
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`New International A��lication Filed with the USPTO as a Receiving Office
`
`
`
`If a new international application is being filed and the international application includes the necessary components for
`
`
`
`
`
`
`
`
`
`an international filing date (see PCT Article 1 1 and MPEP 1 81 0), a Notification of the International Application Number
`Date (Form PCT/R0/1 OS) will be issued in due course, subject to prescriptions
`
`and of the International Filing
`concerning
`
`
`
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`

`
`
`PART B • F'Ji�E(S) TRANSMITTAL
`
`
`Complete and send this fonn, together with applicable f(.-e(s), to: MIDI Mnil Stop ISSUE FEE
`
`
`Commissioner for Patents
`P.O. Box 1450
`
`Alexandria, Virginia 22313-1450
`(571)-273-2885
`orw
`!NSTRlJCTiONS: TJJis form shoultl be used for trnnsrrJitling the ISSliE FEE anti PliBLICATION FEE (if required). Blrxks l thn.> ugh 5 sh<.>uld be n.>mplctcd where
`
`advan ce orders and notitlcntion nf maintenan ce fa:s will be mailed tc, the cum:nt corre�pnndence
`All further com�spondcn.:e
`
`including the Patent,
`appropriah:.
`address as
`address; and/or (b) indicating
`
`unkss oo n"t:l:tt'd bel<JW or direc.t<:'U otherwi�e in Bkx:k 1, by (a) specifying
`a scp:u·.;te "FEE ADDRESS" for ·
`a new t-on"t:spondenct:
`iudicatt'd
`maintenance fee notifications:
`of mailing can only be. used for domestk mailings of the
`Not�.: A
`t•ertifkate
`cannot be used for any other accompanying
`Fee(s) TransmittaL
`This certificate
`
`papers. Each additional papt'r. such ns an assil!nment or f<.unal drawing, must
`have its own .�crtifkatc of mailing or transmissron.
`
`
`Certificate of Mailing or Transmission
`rhat thi� Fcr:(s
`I hereby <'.et1il'v
`·, Trammittal is be.ing dt1positt1d
`wid1 the Unia:d
`p:Jstage for 11rst clilss mail in an envelor,e
`State5 Postal
`
`Service with sufficient
`to thr: Mail Stop ISSUE FEE addt\1ss nhove. or being fM:sirmle
`adrllesst•d
`to the USPTO (571) 273·2885, on the date indicated
`transmitted
`below.
`(Dep<.:Gi�t't;.
`Steven L. Highlander
`(SigntutlP!)
`/Steven L Highlander/
`(DiU¢,)
`August26,2014
`
`tHUllC)
`
`
`
`OSIOPJ20l4
`7590
`108197
`
`
`l'ark(�r Highlander PLLC
`1120 South Capital
`ofTexns Highway
`Bldg. 1, Suite 200
`Austin, TX 7874()
`
`14045156
`INTEFSW 00000206
`08/27/2014
`%0.00 OP
`01 FC:15B1
`
`APPLICATION NO.
`
`F-lLL"iUDATE
`
`FIRST NAMl:D
`
`L"'VE.l\lTOR
`
`ATTORNEY DOCKET NO. CONFIRMATION NO.
`
`John R. PLACHETKA
`PO:Z.N.POfXJ4tJS.CP1C2 1032
`\0103tl013
`\4/045,156
`TITLE OF INVENTION: PHARMACEUTICAL COMPOS1'110NS FOR THE COORDL"'A'IED DELIVERY OF NSAlDS
`
`APPLN.TYPE
`
`El'<ilTY STATUS
`
`!SSTJE l'EE DUE
`
`PUBUCATION FEE DUE PREV. PAiD ISSUE FEE
`
`nonprovi ;;ional l!l\"DISCOUNTED
`
`$960
`
`so
`
`$0
`
`TOTAL l'EE(S)
`$960
`
`DUE
`
`DATE DUE
`
`lli!0/2014
`
`EXAMINER
`
`ART1JNIT
`
`CLASS-SUBCLASS
`
`WESTERBERG, NISSA M
`1618
`424-463000
`i. ChaJ�e
`2. For printing o11llw paten! tlunl page, Jist
`of "F!:C Addtt�ss!'
`(37
`
`of \�orre.spondencc address or indk.aliun
`CPR L63).
`
`·
`·
`(l) The names c,f up to 3 registered
`paten: attornevs
`
`
`W Clmngt' of con"t:�[;'Ond�.ut'e addrt,ss (or Chang� uf Corrt,�pt;nllencc
`or agents OR, alttlrnatively,
`Address fonu P'l O/SBI122)
`attached.
`oamr; of a single t1nn (having a� n membe.r a
`(2) 'Jhc
`registered attorney or agent) and the names of up to
`0 "Fet: Addres>''
`Indication fonn
`(or "Fee Address''
`indkation
`patt1nt atr.orneys or agcot!l. Jf no name is
`2 registe.n'd
`
`
`Re.v 03-02 or more rt'-'ent) :\!Inched. Use of a Customer
`PTO/SB/47;
`3------------�--------
`listed, no name will be printed.
`Number is required.
`3. ASSIGNEE NA..'viE AND RESIDENCE DATA TO BE PRINTED ON THE PATE. 'IT (print or type)
`data will appear on lht' patent. If no a.�signt1e i& idenlifie.d bdow, lh<' documem has been t1Jed for
`
`PLEASE NOTE: Unless an assigtwe
`bdow. no assignee.
`is idemified
`
`recordation as ;et forth in 37 CfR J. I J. Completion of this fonn is NOT a substitute for filing an assignment.
`
`lA) NAME OF ASSIGNEE
`(CITY and STATE OR C01.lNTRYJ
`(B) RESlDf-_:,1\iCE:
`Chapel Hill. NC
`Pozen Inc.
`
`1 Parker Highlander PLLC
`
`.
`
`(will not be printed on the patent): 0 Individual 0 Corporation or other private group entity 0 Government
`Please
`
`
`check the appropriat.� assignee catt�gory Ot' categories
`4b. Payment ,;fFeefs): (Please
`paid issue fee shown nbove)
`4a. The following fee(s)
`art> submitted:
`firH r�:apply any previously
`iKl Issue Pee
`0 A check is enclosed.
`W Publkation Fee (N<.> small emily di�cotmt permitted)
`� Payment by credit card. fonn l"fO 2638 is .tttadtt.d. Vi�l EFS-Web.
`liiJ "lhr: Director
`is hm-chy rmthoti:wd to chaq;:e t.h<;:O.
`
`U Advance Order·· #of Copies ..............................................
`
`any dtlfkiency, or •�mdirs any
`� Utif!:.d ft,e(s).
`to Deposit Account Number 5 -:J�U<:: (endooe an extra copy of this fonn).
`·overpayment,
`
`5. Cltange ill Entity Status (from sr�ru.s indica red above)
`
`
`0 Applicant certifying micro entity status. See. 37 CfR L29
`Absent a valid �:ertifi�:ation of Micro Entity Status (see fonns PTOiSB/15A anu 15B), issue
`
`NQIE;.
`recpiiymr:nt.
`
`in tht� micro entity amoutll will not be accepted n! the Iisk of nppJiCJltiou
`abandonmt�nt.
`U Applicant
`
`was previously under micro entity status, checking this box will be taken
`NQili;.lf the application
`See 37 CFR J .27
`:.mall entity status.
`a.�serting
`
`of lt>>S of entitlement to nticro entity status.
`to be a notification
`of loss of entitlement to small or mien)
`f.J Applicuut
`NOTE: Checking this box will be taken to bt� a
`to t\�gulnr
`f,�, statu